SBFM Stock Summary and Trading Ideas (Sunshine Biopharma | NASDAQ:SBFM)

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Sunshine Biopharma trades on the NASDAQ stock market under the symbol SBFM.

As of September 10, 2026, SBFM stock price declined to $1.08 with 108,864 million shares trading.

SBFM has a beta of 0.95, meaning it tends to be less sensitive to market movements. SBFM has a correlation of 0.00 to the broad based SPY ETF.

SBFM has a market cap of $4.19 million. This is considered a Sub-Micro Cap stock.

Last quarter Sunshine Biopharma reported $9 million in Revenue and -$1.15 earnings per share. This beat revenue expectation by $664,000 and exceeded earnings estimates by $.05.

In the last 3 years, SBFM traded as high as $8,200.00 and as low as $1.01.

SBFM has underperformed the market in the last year with a price return of -92.4% while the SPY ETF gained +17.7%. SBFM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -52.6% and -12.9%, respectively, while the SPY returned +3.1% and -1.1%, respectively.

SBFM support price is $1.05 and resistance is $1.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SBFM shares will trade within this expected range on the day.